Baird Starts Calidi Biotherapeutics Inc (CLDI) at Outperform, 'Delivering Oncolytic Viruses with Stem Cells'
Tweet Send to a Friend
(Updated - October 9, 2023 4:49 AM EDT)
Baird analyst Joel Beatty initiates coverage on Calidi Biotherapeutics Inc (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty initiates coverage on Calidi Biotherapeutics Inc (NYSE ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
